|Home | About | Journals | Submit | Contact Us | Français|
In Wnt signaling, β-catenin and plakoglobin transduce signals to the nucleus through interactions with TCF-type transcription factors. However, when plakoglobin is artificially engineered to restrict it to the cytoplasm by fusion with the transmembrane domain of connexin (cnxPg), it efficiently induces a Wnt-like axis duplication phenotype in Xenopus. In Xenopus embryos, maternal XTCF3 normally represses ventral expression of the dorsalizing gene Siamois. Two models have been proposed to explain the Wnt-like activity of cnxPg: 1) that cnxPg inhibits the machinery involved in the turnover of cytosolic β-catenin, which then accumulates and inhibits maternal XTCF3, and 2) that cnxPg directly acts to inhibit XTCF3 activity. To distinguish between these models, we created a series of N-terminal deletion mutations of cnxPg and examined their ability to induce an ectopic axis in Xenopus, activate a TCF-responsive reporter (OT), stabilize β-catenin, and colocalize with components of the Wnt signaling pathway. cnxPg does not colocalize with the Wnt pathway component Dishevelled, but it does lead to the redistribution of APC and Axin, two proteins involved in the regulation of β-catenin turnover. Expression of cnxPg increases levels of cytosolic β-catenin; however, this effect does not completely explain its signaling activity. Although cnxPg and Wnt-1 stabilize β-catenin to similar extents, cnxPg activates OT to 10- to 20-fold higher levels than Wnt-1. Moreover, although LEF1 and TCF4 synergize with β-catenin and plakoglobin to activate OT, both suppress the signaling activity of cnxPg. In contrast, XTCF3 suppresses the signaling activity of both β-catenin and cnxPg. Both exogenous XLEF1 and XTCF3 are sequestered in the cytoplasm of Xenopus cells by cnxPg. Based on these data, we conclude that, in addition to its effects on β-catenin, cnxPg interacts with other components of the Wnt pathway, perhaps TCFs, and that these interactions contribute to its signaling activity.
Wnts are secreted glycoproteins that are thought to act locally (see Nusse and Varmus, 1992 ; Cadigan and Nusse, 1997 ). A combination of genetic, biochemical, and cell biological studies have led to a consensus model for the Wnt signaling pathway. Binding of a secreted Wnt to Frizzled/Frizzled-2–type receptors (Bhanot et al., 1996 ; Bhat, 1998 ; Kennerdell and Carthew, 1998 ; Muller et al., 1999 ) activates the protein Dishevelled (Dvl) (Yanagawa et al., 1995 ), which in turn leads to the inactivation of glycogen synthase kinase-3β (Gsk3β). Gsk3β, a ubiquitous enzyme (see Yost et al., 1997 ), regulates levels of β-catenin (Siegfried et al., 1992 ) by phosphorylating serine and threonine residues in the N terminus of cytosolic β-catenin (Yost et al., 1996 ) and targeting β-catenin for proteolytic degradation. Thus, in response to a Wnt signal, Gsk3β activity is inhibited and cytosolic β-catenin accumulates and is available to interact with TCF-type transcription factors (Behrens et al., 1996 ; Huber et al., 1996 ; Molenaar et al., 1996 ; Brunner et al., 1997 ; van de Wetering et al., 1997 ), which alter the expression of target genes.
The proteolytic degradation of cytosolic β-catenin and its closely related vertebrate paralogue plakoglobin/γ-catenin appears to involve the product of the adenomatous polyposis coli (APC) gene (Munemitsu et al., 1995 ). β-Catenin and plakoglobin form complexes with APC and Gsk3β (Rubinfeld et al., 1993 , 1995 , 1996 ; Hulsken et al., 1994 ) to target these proteins for ubiquitination and degradation via the proteosome (Aberle et al., 1997 ). Axin and the related protein Conductin/Axil, which negatively regulate the Wnt pathway, link Gsk3β, β-catenin, and APC into a single complex (Yamamoto et al., 1988 ; Zeng et al., 1997 ; Behrens et al., 1998 ; Ikeda et al., 1998 ; Kishida et al., 1998 ; Sakanaka et al., 1998 ). Mutations in APC, responsible for most cases of familial colon cancer, act, at least in part, by increasing the stability of β-catenin (Korinek et al., 1997 ). A substantial number of colon cancers without apparent mutations in APC have mutations in β-catenin that stabilize the cytosolic form of the protein (Morin et al., 1997 ; Sparks et al., 1998 ). Similar mutations in β-catenin have been found in cultured melanoma cell lines (Rubinfeld et al., 1997 ), medulloblastomas (Zurawel et al., 1998 ), pilocytomas (Chan et al., 1999 ), and carcinomas of the liver (de La Coste et al., 1998 ; Miyoshi et al., 1998 ), prostate (Voeller et al., 1998 ), and endometrium (Fukuchi et al., 1998 ; Palacios and Gamallo, 1998 ).
In addition to its role in Wnt signaling, β-catenin plays a critical role in cadherin-mediated cell-cell adhesion, in which it links the classic cadherins of adherens junctions to actin filaments through α-catenin (see Yap et al., 1997 ). Plakoglobin has a similar role at the adherens junction, and expression of either vertebrate plakoglobin or β-catenin in Drosophila can rescue the adhesion defects associated with armadillo mutants (White et al., 1998 ). β-Catenin and plakoglobin have also been found to be associated with the tight junction protein ZO-1 (Rajasekaran et al., 1996 ), the EGF receptor (Hoschuetzky et al., 1994 ; Kanai et al., 1995 ), tyrosine phosphatases (Kypta et al., 1996 ), the actin-bundling protein fascin (Tao et al., 1996 ), the integral membrane protein Presenilin-1 (Zhou et al., 1997 ; Murayama et al., 1998 ; Yu et al., 1998 ), the TATA box–binding protein pontin-52 (Bauer et al., 1998 ), SOX-type transcription factors (Zorn et al., 1999 ) and APC, Axin, and Conductin/Axil (see above). β-Catenin and plakoglobin differ most dramatically in the ability of plakoglobin, but not β-catenin, to bind to desmosomal cadherins (see Gelderloos et al., 1997 ; however, also see Bierkamp et al., 1999 ). Differences in their interactions with adhesion complexes have been observed in vivo (see Nathke et al., 1994 ; Lampugnani et al., 1995 ). In particular, tissues, β-catenin, and plakoglobin can be present at different levels and in different complexes (see Simcha et al., 1998 ).
The HMG-type transcription factors known as lymphoid enhancer factor-1 (LEF1) and T-cell enhancer factors (TCFs), which we refer to generically as TCFs, mediate the final steps in Wnt signaling through their interactions with β-catenin and plakoglobin. The prevailing model for Wnt signaling states that in response to a Wnt stimulus, hypophosphorylated forms of β-catenin or plakoglobin accumulate and form complexes with TCFs. These heterodimeric complexes are then thought to activate transcription at TCF target gene promoters. Alternatively, several lines of evidence suggest that certain TCFs may act as constitutive repressors at target promoters, whose repression is relieved by binding to β-catenin or plakoglobin (see Klymkowsky, 1997 , and below). In Drosophila, mutation of the TCF-binding site in the Ultrabithorax midgut enhancer augments expression of Ubx in cells not exposed to the Wingless protein (Riese et al., 1997 ). A similar derepression is observed upon mutation of TCF sites in the Siamois enhancer, increasing ventral production of Siamois; such mutations have no effect on dorsal expression (Brannon et al., 1997 ). More recent work has solidified the notion of TCFs as transcriptional repressors (see Bienz, 1998 ), e.g., Groucho family members can bind TCFs and mediate constitutive transcriptional repression at TCF-binding sites (Roose et al., 1998 ; see also Cavallo et al., 1998 ; Levanon et al., 1998 ).
We originally constructed membrane-anchored forms of plakoglobin to study whether plakoglobin’s nuclear localization was required to induce axis duplication in Xenopus. When RNAs encoding these polypeptides were injected into fertilized Xenopus eggs, they were effective at inducing axis duplication and did not appear to alter nuclear β-catenin levels (Merriam et al., 1997 ). Based on this result and the inhibitory effects of mutated XTCF3 on axis formation (Molenaar et al., 1996 ), we argued that plakoglobin (and β-catenin) inhibited the repressive activity of maternal XTCF3, allowing the ventral expression of Siamois and other dorsalizing genes (see Klymkowsky, 1997 ; Merriam et al., 1997 ). Subsequently, Miller and Moon (1997) and Hsu et al. (1998) reported that analogous anchored forms of β-catenin inhibit β-catenin degradation and thereby stabilized endogenous β-catenin, arguing that the effects of “anchored catenins” are indirect and dependent on endogenous β-catenin. Most recently, Cox et al. (1999) reported that a “membrane-tethered” form of armadillo did not modulate gene expression in the absence of wild-type armadillo, arguing for an indirect mode of action.
To resolve these apparent discrepancies, we examined further the signaling activities of membrane-anchored plakoglobins using a panel of deletion mutants. Our studies in human 293T and Xenopus A6 cell lines confirm that anchored plakoglobins do act to increase levels of cytosolic β-catenin. However, several lines of evidence indicate that the signaling activity of anchored plakoglobin is not simply due to its effects on cytosolic β-catenin. We show that XTCF3 acts negatively, suppressing the ability of β-catenin to activate a TCF-responsive promoter, and that connexin-plakoglobins (cnxPgs) can sequester TCF family members in the cytoplasm. The results obtained with these admittedly artificial polypeptides raise the intriguing possibility that cytoplasmic forms of catenins may modulate the nuclear availability of TCFs and other negatively acting factors.
For expression of proteins in Xenopus A6 and human 293T cells, we used the pCS2mt plasmid developed by Rupp and Turner (Rupp et al., 1994 ) or the pCDNA3 plasmid (Invitrogen, Carlsbad, CA). For synthesis of cnxPg RNAs for embryo injection, we used the pT7 plasmid described previously (Karnovsky and Klymkowsky, 1995 ; Merriam et al., 1997 ). The pT7cnx-human plakoglobin-myc (pT7cnxPg-myc), pT7cnx-human plakoglobin-green fluorescent protein (pT7cnxPg-GFP), pT7N2ΔPg-myc, and pT7N5ΔPg-myc plasmids have been described previously (Merriam et al., 1997 ; Rubenstein et al., 1997 ). The GFP in these plasmids contains a S65→T mutation that enhances its fluorescence (Heim et al., 1995 ). The N2ΔPg sequence was subcloned into pCS2mt-GFP using EcoRI and XbaI sites to form pCS2mt-N2ΔPg-GFP. To subclone cnxPg into pCS2 plasmids, pT7cnxPg-myc was digested with HindIII and XbaI and the released fragment was subcloned into pCS2mt-GFP. The resulting plasmid has the original SP6 RNA polymerase promoter, 5′ untranslated region, and 6-myc tag region of the pCS2mt plasmid replaced with the T7 RNA polymerase promoter and 5′ β-globin untranslated region of the pT7 plasmid. We refer to these plasmids as pCsCnxPg-GFP. PCR was used to amplify the N3ΔPg and N4ΔPg sequences (5′ N3Δ oligonucleotide CCCGAATTCgcacaacctctcccaccac and 5′ N4Δ oligonucleotide CCCGAATTCgctgcacaacctgctcctg, together with the 3′ full-length human plakoglobin primer CCCCTCTAGAggccagcatgtggtctgc). To create untagged forms of the cnxNΔ2Pg, cnxN3ΔPg, cnxN4ΔPg, and cnxNΔ5Pg polypeptides, the pCsCnx plasmids were digested with XbaI and the DNA ends filled in T4 DNA polymerase and religated, creating an in-frame stop codon between the plakoglobin and GFP sequences. Because of the presence of a second, downstream T7 RNA polymerase promoter in the pCsCnx plasmids, we subcloned the cnxN3ΔPg and cnxN4ΔPg sequences from pCsCnx into the pT7-GFP plasmid using HindIII and XbaI to form pT7cnxN3ΔPg-GFP and pT7cnxN4ΔPg-GFP, which were used for in vitro RNA synthesis (see below).
Plasmids encoding an single HA-epitope–tagged form of Xenopus TCF3 (HA-XTCF3), a single myc-tagged Xenopus LEF-1 (myc-XLEF-1) (Molenaar et al., 1996 , 1998 ), human TCF4 (Korinek et al., 1997 ), mouse and human LEF1 (Travis et al., 1991 ; Waterman et al., 1991 ), a myc-tagged mouse Axin (mtAxin) (Zeng et al., 1997 ), Xenopus Notch (Xotch) (Coffman et al., 1990 ), and a myc-tagged form of Xenopus Dishevelled (mtXDvl) (Sokol, 1996 ) were generously supplied by Hans Clevers and Miranda Molenaar (University of Nijmegen, Nijmegen, The Netherlands), Rudolf Grosschedl (University of California, San Francisco, CA), Katherine Jones (Salk Institute, La Jolla, CA), Michael Sargent (National Institute for Medical Research, Mill Hill, United Kingdom), Frank Costantini (Columbia University, New York, NY), Clark Coffman (University of Colorado, Boulder, CO), and Sergei Sokol (Harvard Medical School, Cambridge, MA), respectively. A myc-GFP–tagged form of the Xenopus zinc-finger transcription factor XSlug has been described elsewhere (Carl et al., 1999 ). The full nucleotide coding regions of XTCF3 and hLEF1 were amplified using PCR (oligonucleotides for XTCF3: 5′-CCCGAATTCGcctcaactaaacagcggcg and 3′-CCCTCTAGAgtcactggatttggtcacc; oligonucleotides for hLEF1: 5′-CCCGAATTCGccccaactttccggagg and 3′-CCCCTCTAGAtcagatgtaggcagctgtcattc). In the case of Xotch, we isolated the cytoplasmic tail domain (5′-CCCGAATTCcaagaagcgtcgccgtgaac and 3′-CCCTCTAGAttacttgaaagcttcagg). The amplified DNAs were digested with EcoRI and XbaI and were subcloned into pCS2mt-GFP (pCS2mtXTCF3-GFP) and pCS2mycGFP (pCS2mGXTCF3, pCS2mGLEF1, and pCS2mGXotchTail) (Figure (Figure1).1). In addition, a form of XTCF3 missing the N-terminal 166 amino acids (pCS2mt-ΔN166-XTCF3-GFP) was generated in a similar manner (oligonucleotides 5′ CCCGAATTCCcacccacttacgcctctcatcacc and the 3′ XTCF3 above). Plasmids expressing an S37→F mutated form of human β-catenin were obtained from Paul Robbins (Surgery Branch, National Cancer Institute, Bethesda, MD). The coding sequence was amplified and subcloned into pCDNA3. Sequence analysis revealed the presence of an additional point mutation in this construct (D32→V). We have subsequently shown that a version of β-catenin containing only a mutation in S37 (S37→A) acts identically in all assays to the D32→V/S37→F (referred to as S37→F) mutant described here (our unpublished results). We have also used the stabilized “pt-mutant” form of Xenopus β-catenin, which was described by Yost et al. (1996) and supplied to us by Aaron Zorn (Wellcome/CRC Institute, Cambridge, United Kingdom). A mutated version of human plakoglobin (S28→A), derived from a human plakoglobin cDNA (Franke et al., 1989 ), was also constructed. The wild-type plasmid was mutagenized using the Stratagene (La Jolla, CA) QuikChange mutagenesis system with primers that placed a silent NgoMI site in the “mutator” oligonucleotide together with the addition of a S→A mutation in the 28th residue. Sequencing confirmed the presence of the expected mutation.
To assay the biological activity of various cnxPg constructs, RNA was synthesized from the T7 promoter of the pT7cnx-GFP plasmids as described previously (Merriam et al., 1997 ). Fertilized eggs were injected with 10–20 nl of RNA (0.01–0.8 ng/nl). Injected embryos were examined using a Leitz (Midland, Ontario, Canada) M5 stereo dissecting microscope equipped with epifluorescence optics to identify those expressing the exogenous protein. The effects of the injected RNAs on axis formation were assayed at stages 15–20; axis duplication was based on the presence of two distinct neural axes (see Merriam et al., 1997 ).
Xenopus A6 cells were cultured on glass coverslips in 85% Leibowitz L15 medium supplemented with 10% FCS and antibiotics and grown at room temperature. Injection of plasmid DNAs (1–10 μg/ml) was carried out as described previously (Klymkowsky, 1999 ). Green fluorescence was first visible within 2–4 h of injection. Living cells were examined using a Zeiss (Thornwood, NY) IM35 microscope equipped with appropriate filter sets; images were captured on slide film (Ektachrome 400, Kodak, Rochester, NY) or on an Apple (Cupertino, CA) Power Macintosh 6500/275 computer using a Microimage (Boyertown, PA) i308 video camera and the Minimonitor 1.2 program.
Cells were fixed with 70% acetone/30% ethanol for 5 min, rehydrated in Tris-buffered saline (TBS), and stained with appropriate antibodies. GFP autofluorescence were visualized directly using fluorescein optics. The mouse anti-plakoglobin (γ-catenin) (Transduction Laboratories, Lexington, KY) mAb was used to visualize untagged plakoglobin-containing polypeptides; its epitope is located in the C-terminal region of plakoglobin and is present in all versions of plakoglobin used here. A rabbit anti-Xenopus plakoglobin antibody, obtained from Thomas Kurth and Peter Hausen (Max Planck Institute, Tubingen, Germany), was used in some studies. myc-tagged polypeptides were visualized using the mouse anti-myc mAb 9E10 (Evan et al., 1985 ). APC was visualized using a rabbit antiserum directed against the C-terminal region of APC (Santa Cruz Biotech, Santa Cruz, CA). Western immunoblot studies, carried out by Richard Nelson and Barry Gumbiner (Sloan-Kettering Memorial Cancer Center, New York, NY) with baculovirus-synthesized Xenopus APC, indicate that this anti-APC antiserum reacts specifically with Xenopus APC (R. Nelson and B. Gumbiner, personal communication; and our unpublished results). A mouse anti-E-cadherin antibody (Transduction Laboratories) was used to visualize E-cadherin. β-Catenin was visualized using a rabbit anti-β-catenin antibody (supplied by Pierre McCrea, University of Texas, Houston, TX; see McCrea et al., 1993 ; Fagotto and Gumbiner, 1994 ). Bound antibodies were recognized using either fluorescein-, Texas Red- (Southwestern Biotechnology, Birmingham, AL), Alexa 488-, or Alexa 495- (Molecular Probes, Eugene, OR) conjugated species-specific secondary antibody conjugates. Cells were mounted in airvol/glycerol and viewed using a Zeiss IM35 microscope and photographed onto Kodak Ektachrome 400 film, as described by Carl and Klymkowsky (1999) . Slides were digitized using a Polaroid (Cambridge, MA) SprintScan 35plus slide scanner. Alternatively, cells were visualized using a Nikon (Tokyo, Japan) upright epifluorescence microscope with a ×100 lens, and the images were captured using a Cooke (Auburn Hills, MI) Sensicam video camera on a PowerMacintosh 8500/150MHz computer using the SlideBook 2.1 program (Intelligent Imaging Innovations, Denver, CO). Images were deconvoluted using the SlideBook program and exported as TIFF files. Images were manipulated using Photoshop 4.0 (Adobe, Mountain View, CA) software, and final figures were prepared using Illustrator 7.0 (Adobe).
To measure the ability of various forms of cnxPg to activate a TCF-dependent reporter construct, human 293T cells were cotransfected with the plasmid to be tested, an optimized version of the TOPFLASH reporter plasmid (OT) (Korinek et al., 1997 ) (supplied by Bert Vogelstein, Johns Hopkins University, Baltimore, MD), and the pCDNA3.1-lacZ plasmid. Transfections were performed in duplicate. For each experiment, 60-mm plates were seeded with equal numbers of cells on the night before transfection. A CaPO4-based transfection method was used for all transfections with Stratagene Stable Mammalian Transfection Kits. Cells were 30–50% confluent at the time of transfection. Cells were harvested 36 h after transfection by lysing in 1× reporter lysis buffer (Promega, Madison, WI). Lysates were pelleted and 10 μl of each supernatant was added to 100 μl of luciferase assay substrate (Promega). Luciferase activity was measured (with duplicate readings for each sample) using a Berthold (Bad Wildbad, Germany) Lumat LB9507 luminometer. Readings were normalized for transfection efficiency by measuring β-galactosidase activity. To monitor the accumulation of cnxPgs, cell lysates were analyzed by immunoblot (see below) using mouse mAbs directed against either plakoglobin (Transduction Laboratories) or GFP (Boehringer-Mannheim, Indianapolis, IN).
Total RNA was extracted from human 293T cells and Jurkat lymphoma cells using a Qiagen (Valencia, CA) RNeasy kit. The RNA was reverse transcribed into cDNA using a Life Technologies/BRL (Bethesda, MD) one-step reverse transcriptase-PCR kit using 1 μl of RNA at 1 μg/ml, according to the manufacturer’s protocol. PCR was carried out under the following cycling conditions: 1 time at 50°C for 3 min, 30 times at 94°C for 2 min, 94°C for 25 s, 56°C for 30 s, and 72°C for 2 min, and 1 time at 72°C for 15 min. PCR products were resolved on a 2% NuSieve FMC (Rockland, ME) agarose gel. The oligonucleotides used for the PCR analysis were: TCF1 5′, 5′ TCA AGA AGC CCC TCA ATG CC 3′; TCF1 3′, 5′ TTG GTG CTT TTC CCT CGA CC 3′; LEF1 5′, 5′ CAG AAG GAA AAG ATC TTC GC 3′; LEF1 3′, 5′ GTA GGA GGG TCC CTT GTT GTA 3′; TCF3 5′, 5′ CAG TCA CAG CAG CAA GTT TAG GAG 3′; TCF3 3′, 5′ GGG TTT CTG GTT TGG TGG TGA AG 3′; TCF4 5′, 5′ TCC AGA GAA GAG CAA GCG AAA TAC 3′; and TCF4 3′, 5′ TGA GGT CTG TAA TCG GAG GAA GTG 3 ′.
To examine the effects of cnxPgs on cytosolic β-catenin levels, samples were prepared as described by Shimizu et al. (1997) . Cultures of 293T cells were transfected with 4 μg of plasmid DNA. Thirty-six hours after transfection, cells were harvested in 10 mM Tris (pH 7.5), 140 mM NaCl, and 2 mM DTT supplemented with protease inhibitors. The samples were then scraped from the plates, lysed in a Dounce homogenizer, and centrifuged for 1 h at 100,000 × g at 4°C. Supernatants were removed and diluted in SDS-sample buffer. The diluted sample was then separated on a 10% SDS-PAGE gel and transferred to nitrocellulose. After confirming even transfer by staining with Ponceau S, the blot was incubated for 30 min at room temperature in blocking solution (0.1% Tween-20 in TBS with 5% BSA). Blots were incubated for 12–16 h at 4°C with primary antibody against anti-β-catenin (Transduction Laboratories) diluted 1:1,000 in blocking solution. Blots were washed three times (5–10 min per wash) in 0.1% Tween-20 in TBS, incubated in secondary antibody (goat anti-mouse immunoglobulin G–peroxidase), diluted 1:15,000 in blocking solution for 30 min at room temperature, washed three times for 10–15 min in Tween-20 in TBS, exposed to ECL substrate (Amersham, Arlington Heights, IL), and exposed to film.
Three assays are commonly used to study the Wnt signaling activity of a polypeptide: its ability to induce an ectopic dorsal axis in Xenopus, to activate a TCF-responsive reporter plasmid, and to stabilize soluble β-catenin. Previously, we found that injection of RNAs encoding membrane-anchored forms of plakoglobin led to the synthesis of cytoplasmic proteins that induced an ectopic dorsal axis in Xenopus embryos but had no apparent effect on nuclear β-catenin levels (Merriam et al., 1997 ). To study further the mechanism of cnxPg action, we created a panel of GFP-tagged (and untagged) cnxPg deletion mutants (Figure (Figure1).1). The mutations removed the entire N-terminal domain of plakoglobin together with the first (cnxN2ΔPg, starts at Asn-167 of plakoglobin), second (cnxN3ΔPg, starts at His-210), third (cnxN4ΔPg, starts at Leu-250), or fourth (cnxN5ΔPg, starts at Gln-292) Arm repeats (Figure (Figure1).1). Based on the original definition of the Arm repeats, these deletions leave the last five to eight amino acids of the N-terminal deleted Arm repeat, as defined structurally in β-catenin (Huber et al., 1997 ).
To compare the signaling activity of cnxPg with that of plakoglobin and β-catenin, we used full-length and deleted versions of plakoglobin (Karnovsky and Klymkowsky, 1995 ; Rubenstein et al., 1997 ) and a mutated version (S28→A) of plakoglobin analogous to the S37→A oncogenic mutation described for β-catenin. In addition, the pt-mutant version of Xenopus β-catenin (Yost et al., 1996 ) was also tested. Oncogenic mutations in β-catenin lead to the stabilization of the cytoplasmic form of the protein and greatly enhance its ability in Wnt-signaling assays (see Yost et al., 1996 ; Morin et al., 1997 ).
Previously, we found that a unanchored N5Δ version of plakoglobin induced axis duplication in Xenopus (Rubenstein et al., 1997 ). To determine whether the same N-terminal region was required for the signaling activities of anchored plakoglobin, we tested the ability of RNAs encoding the various cnxPg deletion mutations to induce the formation of an ectopic axis when injected into fertilized Xenopus eggs. As previously reported, injection of cnxPg-GFP mRNA induced axis duplication (Merriam et al., 1997 ) (Figure (Figure2A).2A). Injection of cnxN3ΔPg-GFP RNA also induced axis duplication, whereas injection of cnxN4ΔPg-GFP RNA did not (Figure (Figure2A).2A). Based on the intensity of green fluorescence, the products of all tested constructs appeared to accumulate to roughly equal extents. To determine if the N3Δ deletion decreased the efficiency of axis induction, embryos were injected with various amounts of cnxPg-GFP and cnxN3ΔPg-GFP RNAs; cnxN3ΔPg-GFP RNA was less efficient than equivalent amounts of cnxPg-GFP RNA at inducing axis duplication (Figure (Figure22A).
We next examined the ability of the cnxPg deletion constructs to transactivate a TCF-responsive reporter, OT, when cotransfected into 293T cells. The OT plasmid contains three copies of a TCF-binding motif (CCTTTGATC) upstream of a minimal c-fos promoter. All transfections also included a plasmid encoding LacZ (pCDNA3.1-βgal) to normalize for transfection efficiency by measurement of β-galactosidase activity. Reverse transcriptase-PCR analysis of 293T cells indicated that they expressed detectable levels of all four TCF RNAs, i.e., TCF1, LEF1, TCF3, and TCF4; in contrast, human Jurkat cells expressed detectable levels of TCF1 and LEF1 only (Figure (Figure2B).2B). The OT reporter was efficiently activated by a S37→F “stabilized” (oncogenic) mutant form of β-catenin (Figure (Figure2C).2C). cnxPg and cnxN2ΔPg were equally effective, and typically as or more effective than oncogenic β-catenin, at activating the OT reporter (Figure (Figure2C2C and Table Table1).1). cnxN3ΔPg was significantly less effective, although it still consistently activated OT 5- to 10-fold above background. cnxN4ΔPg and cnxN5ΔPg did not activate the OT reporter. Interestingly, the N2Δ form of plakoglobin (Figure (Figure2C)2C) activated the reporter only weakly, even though it induced axis duplication in Xenopus (Rubenstein et al., 1997 ). A variant of OT containing point mutations that prevent TCF binding to the three TCF-binding motifs was not activated above basal levels by any of the constructs described here (our unpublished results).
Western blot analysis of extracts from cells transfected with these constructs indicated that similar amounts of each polypeptide were produced (Figure (Figure2D).2D). We also assayed the effects of transfection of the various cnxPgs into 293T cells on the levels of soluble β-catenin (Figure (Figure2E).2E). cnxPg and cnxN2ΔPg were equally effective at increasing the concentration of soluble β-catenin, whereas cnxN3ΔPg was less effective and cnxN4ΔPg stabilized soluble β-catenin only very weakly. As reported previously by Miller and Moon (1997) and Simcha et al. (1998) , expression of wild-type plakoglobin increased soluble β-catenin (our unpublished results); in contrast, expression of N2ΔPg failed to induce a detectable increase in soluble β-catenin (Figure (Figure2E).2E). The ability of cnxPg to stabilize cytosolic β-catenin was similar to that seen in cells transfected with plasmid encoding Wnt-1 (Figure (Figure2F);2F); however, the ability of cnxPg to activate the OT reporter was much greater than that seen with Wnt-1 (Figure (Figure2G).2G). Transfection with the Wnt-1 plasmid increased reporter activity 2- to 10-fold, compared with the 50- to 150-fold activation seen with cnxPg. Therefore, it seems likely that the stabilization of β-catenin is not the only factor that determines the level of signaling induced by cnxPg.
The response of the OT reporter to β-catenin is presumably mediated by TCFs. TCFs are reported not to activate TCF-dependent reporters on their own, but coexpression of TCFs and β-catenin enhances reporter activation over the levels seen with either alone (see Korinek et al., 1997 ; Hsu et al., 1998 , and references therein). Therefore, if activation of OT by cnxPg were due solely to cnxPg’s effects on β-catenin levels, increasing TCF levels should enhance OT activation by cnxPg. To test this hypothesis, we examined the effects of expressing various TCFs on the ability of β-catenin and cnxPg to activate the OT reporter. These studies led to several surprising observations. First, it is clear that different TCFs behaved quite differently in this assay system (Figure (Figure3).3). Transfection of 293T cells with mLEF1 alone consistently activated OT activity 10- to 20-fold above baseline (Figure (Figure3,3, A and C), whereas transfection of either hTCF4 (Figure (Figure3E)3E) or XTCF3 (Figure (Figure3G)3G) alone failed to activate OT. Cotransfection of LEF1 or hTCF4 with oncogenic forms of β-catenin resulted in a large increase in OT reporter activation (Figure (Figure3,3, A and E) well beyond the strong activation induced by oncogenic β-catenin alone. A similar synergistic activation of OT was observed when cells were transfected with the S28→A mutant form of plakoglobin and LEF1 (Figure (Figure3B).3B).
Previously, Molenaar et al. (1996) reported that XTCF3 enhanced the ability of β-catenin to activate a TCF-dependent reporter. In contrast, we found that cotransfection of XTCF3 and either the human or Xenopus β-catenin suppressed β-catenin’s ability to activate OT by approximately twofold (Figure (Figure3G).3G). DNA-binding studies indicate that XTCF3 binds to β-catenin and that the XTCF3/β-catenin complex binds to a TCF-DNA consensus sequence (our unpublished results). The reason behind the discrepancy between our results and those of Molenaar et al. (1996) is unclear, but the ability of XTCF3 to suppress β-catenin signaling is consistent with its activity in the Xenopus embryo (see below).
Contrary to what would have been expected if cnxPg activated OT solely by increasing the level of cytosolic β-catenin, coexpression of cnxPg with either mLEF1 (Figure (Figure3C)3C) or hTCF4 (Figure (Figure3F)3F) suppressed cnxPg’s ability to activate OT. XTCF3’s effect on cnxPg was similar to its effect on β-catenin, i.e., coexpression of XTCF3 suppressed activation of the OT reporter by cnxPg (Figure (Figure3H).3H). The inhibitory effects of TCFs on cnxPg reporter activity were not due to effects on cytosolic levels of β-catenin, because cotransfection with mLEF1 or XTCF3 did not affect the levels of cytosolic β-catenin induced by cnxPg (Figure (Figure33D).
To gain more insight into the actions of cnxPgs on signaling, we tested their abilities to alter the localization of various Wnt signaling components in Xenopus A6 cells. Because transfection efficiencies are low in Xenopus cells by conventional methods, we injected DNAs encoding cnxPgs directly into nuclei (see Klymkowsky, 1999 ). The encoded cnxPgs tended to form irregular cytoplasmic aggregates and did not appear to enter the plasma membrane efficiently (Figures (Figures4A4A and 5, G and J). Occasionally, cnxPgs were seen in a reticular pattern (see Figure Figure8,8, E and I, for examples) likely to represent the endoplasmic reticulum (our unpublished results). In contrast, unanchored forms of plakoglobin accumulate largely in the nuclei in living and fixed cells (Karnovsky and Klymkowsky, 1995 ; Merriam et al., 1997 ; Rubenstein et al., 1997 ) (Figure (Figure5D).5D).
Consistent with our biochemical studies of soluble β-catenin (see above) and the observations of Miller and Moon (1997 ; see also Hsu et al., 1998 ), A6 cells injected with cnxPg DNA often displayed increased levels of nuclear β-catenin (Figure (Figure4).4). However, this effect was quite variable between cells and did not always correlate with the level of cnxPg expression (Figure (Figure4,4, A–C). It is perhaps this variability that obscured an increase in nuclear β-catenin in embryonic cells expressing cnxPg (see Merriam et al., 1997 ). Injection of the cnxN3ΔPg plasmid increased nuclear β-catenin in some cells (Figure (Figure4,4, C and D), whereas expression of the cnxN4ΔPg-GFP polypeptide had no apparent effect on β-catenin’s intracellular localization (Figure (Figure4,4, E and F).
Axin and the related protein Conductin/Axil bind to β-catenin in a complex with APC and Gsk3β (see above). To determine whether Axin could colocalize with cnxPgs, we coinjected DNAs encoding wild-type mtAxin (Zeng et al., 1997 ) into A6 cells either alone (Figure (Figure5,5, A–C) or together with DNA encoding either N2ΔPg-GFP (Figure (Figure5,5, D–F) or cnxPgs (Figure (Figure5,5, G–O). After injection of mtAxin DNA alone, mtAxin was found in irregular aggregates scattered throughout the cytoplasm and excluded from the nucleus (Figure (Figure5,5, A–C). When DNAs encoding mtAxin and N2ΔPg-GFP were coinjected, green fluorescence from the N2ΔPg-GFP polypeptide was almost entirely nuclear, whereas mtAxin was found in aggregates scattered throughout the cytoplasm and within the nuclei (Figure (Figure5,5, D–F). When mtAxin and cnxPg-GFP DNAs were coinjected, the two polypeptides colocalized (Figure (Figure5,5, G–I). Deletion of plakoglobin’s N-terminal head and first two Arm repeats (cnxN3ΔPg-GFP) did not disrupt the colocalization of mtAxin with cnxPg (Figure (Figure5,5, J–L), whereas deletion of the third Arm repeat (cnxN4ΔPg-GFP) abolished colocalization (Figure (Figure5,5, M–O). In human 293T cells, coexpression of mtAxin with cnxPg suppressed cnxPg’s ability to activate the OT reporter by 40–60% (our unpublished results).
APC forms a complex with β-catenin or plakoglobin (see above), targeting these catenins for proteolytic degradation. In Xenopus A6 cells, anti-APC antibody stained both nuclei and cytoplasm diffusely, and staining of the cell boundary was sometimes visible (Figure (Figure6,6, H and I) (see Neufeld and White, 1997 ; Senda et al., 1998 ). In cells expressing cnxPg-GFP (Figure (Figure6,6, A–C), anti-APC staining colocalized with cnxPg-GFP. APC colocalized with cnxN3ΔPg (Figure (Figure6,6, D–F) but not with cnxN4ΔPg (Figure (Figure6,6, G–I) or cnxN5ΔPg (our unpublished results).
Chitaev et al. (1996) showed that membrane-anchored forms of plakoglobin were capable of interacting with desmosomal cadherins, whereas Cox et al. (1999) reported that anchored forms of Armadillo localized to the plasma membrane and coimmunoprecipitated with DE-cadherin. However, cnxPgs do not efficiently reach the plasma membrane in A6 cells (see above), and double-label immunofluorescence microscopy revealed little overlap between cnxPgs and E-cadherin (Figure (Figure7,7, A and B).
Genetic studies indicate that Dishevelled is activated in response to Wnt signaling and plays a role in the inhibition of Gsk3β. To determine if the expression of cnxPg altered the distribution of Dishevelled, we coexpressed cnxPg-GFP with a myc-tagged form of Xenopus Dishevelled (Sokol, 1996 ) in A6 cells. Exogenous Dishevelled was distributed throughout the cytoplasm and excluded from the nucleus (Figure (Figure7C).7C). The presence of cnxPg had no apparent effect on the distribution of Dishevelled (Figure (Figure7,7, E–G).
We have previously proposed that cnxPgs act, at least partially, by sequestering and inhibiting negatively acting factors in the cytoplasm. The ability of cnxPgs to sequester Axin and APC supports such a model. To determine whether cnxPgs could also sequester TCFs in Xenopus cells, we coexpressed them with either a myc-tagged form of XLEF1 or myc- and GFP-tagged forms of XTCF3 and hLEF1 (Figure (Figure1).1). When expressed on their own, XLEF1 (Figure (Figure7D)7D) and XTCF3 (Figure (Figure8C)8C) were exclusively nuclear. When DNAs encoding XLEF and cnxPg (Figure (Figure7,7, H–J) or XTCF3 and cnxPg (our unpublished results) were coinjected, a significant amount of fluorescent signal was observed in the cytoplasm. Cytoplasmic localization of exogenous TCFs was observed in cells expressing cnxN2ΔPg (Figure (Figure8,8, A and B) or cnxN3ΔPg (Figure (Figure8D)8D) but not in cells expressing cnxN4ΔPg (Figure (Figure8,8, E and F) or cnxN5ΔPg (our unpublished results). This cytoplasmic localization of exogenous TCFs was not an artifact of fixation, because it could be readily observed in living cells (Figure (Figure8D).8D).
The colocalization of XTCF3 and β-catenin requires the presence of the “catenin-binding domain” located at the N terminus of XTCF3 and LEF1 (Molenaar et al., 1996 ). A version of XTCF3 with this domain deleted (mtΔN166XTCF3-GFP) failed to colocalize with cnxPg (Figure (Figure7,7, G and H). Similarly, we found no apparent colocalization between cnxPg and tagged forms of the cytoplasmic tail domain of Xenopus Notch, the zinc-finger transcription factor XSlug, or the bHLH transcription factor NeuroD (our unpublished results), all of which localized to nuclei. This finding suggests that the colocalization between cnxPg and TCFs is not due to nonspecific interactions between highly expressed proteins in these cells.
Recently, our understanding of the mechanisms underlying Wnt signaling has deepened considerably. After the discovery of the interaction between β-catenin or plakoglobin and TCFs, it was commonly held that β-catenin and plakoglobin acted exclusively as transcriptional coactivators. It was already clear, however, that such a model did not accurately describe one important model system of Wnt-like signaling, i.e., dorsal axis formation in Xenopus (see Klymkowsky, 1997 ). XTCF3, the only TCF so far detected in the early embryo at the time of dorsal determination (see Molenaar et al., 1998 ), does not by itself induce axis duplication. In fact, overexpression of XTCF3 partially suppresses dorsal axis formation (Zorn et al., unpublished observations), and a mutated form of XTCF3, missing its catenin-binding domain, blocks dorsal differentiation (Molenaar et al., 1996 ). Analysis of the promoter region of the homeobox gene Siamois, a target of Wnt/β-catenin transcriptional regulation in the early Xenopus embryo (Carnac et al., 1996 ), indicates that XTCF3 represses expression ventrally but does not appear to stimulate expression dorsally (Brannon et al., 1997 ; see also Fan et al., 1998 ). In contrast to Molenaar et al. (1996) , we found that XTCF3 fails to enhance activation of the TCF-responsive OT reporter by β-catenin, but rather suppresses it (Figure (Figure3G).3G). The origin of this discrepancy is unclear. We have confirmed the sequence of the XTCF3 construct used in our studies and shown that XTCF3 binds to a TCF DNA consensus sequence and that the XTCF3/DNA complex binds to β-catenin (our unpublished results). Perhaps differences in the TCF-responsive reporters and cell lines used are responsible, although the repressive effects of XTCF3 on OT activity are more consistent with the effects of XTCF3 overexpression observed in the Xenopus embryo (see Molenaar et al., 1996 ; Klymkowsky, 1997 ). In any case, the negative effects of XTCF3 are consistent with a model in which anchored forms of plakoglobin induce Wnt-like axis duplication in Xenopus, at least in part, by repressing XTCF3 activity, thereby allowing the ectopic expression of Siamois and other directly dorsalizing genes (Figure (Figure9)9) (see Klymkowsky, 1997 ).
The proposal that membrane-anchored forms of plakoglobin or β-catenin act solely by inhibiting the activity of XTCF3 has been challenged. Miller and Moon (1997) provided clear evidence that expression of a membrane-anchored β-catenin leads to the accumulation of soluble β-catenin, presumably by inhibiting the β-catenin turnover system (see also Hsu et al., 1998 ; Simcha et al., 1998 ). Although we previously did not detect an increase in nuclear β-catenin levels in embryonic cells expressing anchored plakoglobins (Merriam et al., 1997 ), it now seems likely that the methodologies used were not sensitive enough to detect the small changes in β-catenin levels involved (see Figure Figure44 for example), particularly in the presence of the high basal levels of nuclear β-catenin present at the embryonic stage examined. Our own subsequent studies, presented here, confirm that anchored plakoglobins do stabilize cytosolic β-catenin in both Xenopus A6 (Figure (Figure4)4) and human 293T cells (Figure (Figure2D),2D), presumably by interacting with negative factors, i.e., APC (Miller and Moon, 1997 ) (Figure (Figure6)6) and Axin (Figure (Figure5).5). Thus, the idea that anchored plakoglobins or β-catenins act, at least in part, by stabilizing soluble β-catenin is well established.
Our analysis indicates that the N-terminal head and the first Arm repeat of plakoglobin can be removed from cnxPg without abolishing the ability to colocalize with Axin and APC (Figures (Figures55 and and6).6). Removal of the second Arm repeat (cnxN3ΔPg), however, impaired the ability of the polypeptide to induce axis duplication (Figure (Figure2A),2A), activate the OT reporter (Figure (Figure2C),2C), and stabilize β-catenin (Figure (Figure2E).2E). Removal of the third Arm repeat (cnxN4ΔPg) completely abolished axis duplication activity and the ability to activate the OT reporter and greatly reduced, although it did not eliminate, the stabilizing effect on β-catenin (Figure (Figure2,2, A, C, and E). The cnxN4ΔPg and cnxN5ΔPg polypeptides also failed to colocalize with either Axin or APC (Figures (Figures5,5, M–O, and 6, G–I). Interestingly, a N5Δ version of plakoglobin induces axis duplication in Xenopus (Rubenstein et al., 1997 ), arguing for differences in the Wnt-signaling mechanisms of the “free” and anchored forms of the protein.
Our analysis of cnxPg in vertebrate cells suggests that cnxPgs do not act exclusively through effects on β-catenin. First, expression of either cnxPg or Wnt-1 in 293T cells results in similar levels of soluble β-catenin (Figure (Figure2F).2F). A comparable stabilization of β-catenin in NIH 3T3 cells by membrane-tethered β-catenin or Wnt-1 was observed by Hsu et al. (1998) . Despite similar effects on cytosolic β-catenin levels, anchored plakoglobins transactivated the OT reporter to levels 10- to 20-fold greater than did Wnt-1 (Figure (Figure2G2G and Table Table11).
Second, work from several laboratories has shown that β-catenin and LEF1 or TCF4 act synergistically to transactivate OT and other similar reporters when cotransfected into a number of cell types (see Korinek et al., 1997 ; Hsu et al., 1998 ). We confirmed these observations by showing that an oncogenic form of β-catenin, when coexpressed with LEF1 or hTCF4, strongly induced reporter activity (at least 4-fold above the levels induced by β-catenin alone and up to 300-fold over baseline activity) (Figure (Figure3,3, A and E).
Miller and Moon (1997) suggested that plakoglobin acts to induce axis duplication indirectly through effects on β-catenin stability. In cultured cells, expression of plakoglobin stabilizes endogenous β-catenin (Simcha et al., 1998 ), and coexpression of plakoglobin with LEF1 produces a similar synergistic activation of the OT promoter (Figure (Figure3B).3B). Although this may be true for full-length plakoglobin, it does not seem to be the case for deleted forms of the protein, because the N2Δ form of plakoglobin induces axis duplication (Rubenstein et al., 1997 ) but does not appear to alter cytoplasmic β-catenin levels (Figure (Figure22E).
If cnxPg’s signaling activity were due solely to its ability to increase β-catenin levels, we would predict a similar synergism in OT activation between cnxPg and TCFs. Instead, coexpression of cnxPg and LEF1 or hTCF4 inhibited cnxPg-induced OT transactivation (Figure (Figure3,3, C and F). One possible mechanism to explain such an inhibition is that the binding of TCFs to cnxPg blocks the interaction between cnxPg, Axin, and APC, leading to a decrease in cytoplasmic β-catenin. This does not appear to be the case, however. Coexpression of LEF1 or XTCF3 and cnxPg does not appear to decrease the cnxPg-induced stabilization of β-catenin (Figure (Figure33D).
One potential explanation for the behavior of cnxPg emerges from the model we originally proposed, namely, that cnxPg alters gene expression, at least in part, by sequestering in the cytoplasm a molecule that normally represses relevant target genes involved in Xenopus axis induction (Figure (Figure9).9). A growing body of evidence supports the idea that TCFs, and XTCF3 (Figure (Figure2G)2G) in particular, have the characteristics of such a molecule (see above; Klymkowsky, 1997 ; Bienz, 1998 ). Mutation of TCF sites in the Ultrabithorax and Siamois promoters of Drosophila and Xenopus, respectively (Brannon et al., 1997 ; Riese et al., 1997 ; Fan et al., 1998 ), derepresses expression of these genes in cells not exposed to Wingless/Wnt signals. Furthermore, Groucho-like corepressor proteins bind to XTCF3 and, as a complex, XTCF3 and Groucho can constitutively repress transcription at promoters with TCF-binding sites (Roose et al., 1998 ).
To examine the possibility that cnxPgs can bind to and sequester TCF-type transcription factors in the cytoplasm, we examined the behavior of myc- and GFP-tagged forms of XLEF1 and XTCF3. Nuclear when expressed on their own (Figures (Figures7D7D and and8C),8C), both XLEF1 (Figure (Figure7,7, H–J) and XTCF3 (Figure (Figure8,8, B and D) were found to accumulate to readily detectable levels in the cytoplasm of cells expressing cnxPg. The cytoplasmic localization of GFP-tagged TCFs could be observed in living cells (Figure (Figure8D),8D), ruling out any artifactual redistribution of the protein during fixation. Staining of fixed cells showed a close association between exogenous TCFs and cnxPgs (Figures (Figures7,7, H–J, and 8, A and B).
The specificity of the colocalization between cnxPg and TCFs was demonstrated in two ways. The colocalization of TCFs and β-catenin involves the N-terminal region of these DNA-binding proteins (Behrens et al., 1996 ; Molenaar et al., 1996 ). When a mutated version of XTCF3 lacking the N-terminal 166 amino acids was tested, it did not colocalize with cnxPg (Figure (Figure8,8, E and F). We have tested a number of other identically tagged transcription factors and nuclear proteins, including the Xenopus zinc-finger transcription factor XSlug, the cytoplasmic domain of the Xenopus Notch homologue Xotch, and the mouse HLH transcription factor NeuroD. None of these polypeptides showed any tendency to colocalize with cnxPg (our unpublished results). Based on these data, we conclude that cnxPg specifically interacts with, and can sequester, exogenous TCFs in the cytoplasm of Xenopus cells. Because Wnt-1 and cnxPg induce similar increases in β-catenin levels (Figure (Figure2F)2F) but differ significantly in their signaling activity (as measured by OT activation) (Figure (Figure2G),2G), we suggest that inhibition of the repressive activities of TCF family members may, at least in part, account for this difference. Alternatively, cnxPg may either activate some other activator or inhibit some other repressor of TCF signaling, distinct from β-catenin, APC, Axin, or TCF.
How does the ability of cnxPg to sequester a portion of exogenous TCFs in somatic cells relate to its effects in the Xenopus embryo? This question clearly requires an analysis of the effects of cnxPg on endogenous TCFs; we are currently generating anti-XTCF3 antibodies to directly examine this issue. However, it is clear that in somatic cells cnxPgs can sequester at least a portion of total exogenous TCFs in the cytoplasm. In the early Xenopus embryo, which breaks down its nuclei every 30–40 min during the period of axis determination (Newport and Kirschner, 1982 ), the likelihood that cnxPgs can significantly affect the intracellular distribution of endogenous XTCF3 seems even more likely.
Based on all of the data presented here, we propose that cnxPg acts by two distinct mechanisms to affect Wnt signaling (Figure (Figure9A).9A). It inhibits the negatively acting cytoplasmic proteins Axin and APC (Figures (Figures55 and and6),6), thereby stabilizing β-catenin (Figures (Figures22 and and4).4). This is the mechanism originally proposed by Miller and Moon (1997) . On the other hand, cnxPg can also clearly sequester exogenous TCFs to the cytoplasm of Xenopus A6 cells (Figures (Figures77 and and8),8), and its ability to activate the OT reporter is inhibited, rather than activated, by TCF coexpression (Figure (Figure3),3), suggesting that TCFs may compete for binding sites on cnxPg for negatively acting factors. Clearly, it is the relative levels of specific TCFs expressed in a specific cell type, combined with their relative affinities for β-catenin, plakoglobin, and other accessory factors (e.g., Groucho-like proteins, pontin-52, ALY, etc.), that is critical for determining the outcome of cnxPg expression.
To further study the signaling activities of cytoplasmic catenins, it is necessary to uncouple cnxPg’s ability to increase cytoplasmic levels of β-catenin from its ability to bind TCFs and other regulatory proteins. Cox et al. (1999) performed such an analysis in Drosophila using a membrane-tethered form of Armadillo. Drosophila appears to have a single TCF-type protein, pangolin/dTCF, which can act both positively, in conjunction with Armadillo (Brunner et al., 1997 ; van de Wetering et al., 1997 ), and negatively, in combination with dCBP (Waltzer and Bienz, 1998 ) and Groucho (Cavallo et al., 1998 ). In the presence of the “nearly null” allele of armadillo, armXP33, Cox et al. (1999) found no evidence that anchored Armadillo altered target gene expression. However, there is an important caveat to this conclusion: tethered armadillo rescues the adhesion defects associated with armadillo mutations and interacts with DE-cadherin, as demonstrated by coimmunoprecipitation analyses (Cox et al., 1999 ). It is known from studies in Xenopus (see Heasman et al., 1994 ; Karnovsky and Klymkowsky, 1995 ; Fagotto et al., 1996 ) and Drosophila (Sanson et al., 1996 ) that binding to cadherin blocks the signaling activities of armadillo, β-catenin, and plakoglobin. Therefore, it is likely that the signaling function of tethered armadillo is inhibited by interactions with DE-cadherin (see Figure Figure9B).9B). Moreover, the absence of wild-type armadillo would be expected to enhance the interaction between tethered armadillo and endogenous cadherins. In contrast, cnxPg does not efficiently reach the plasma membrane in (Figure (Figure7,7, A and B; see also Merriam et al., 1997 ), and there appears to be no substantial colocalization of cnxPg with endogenous cadherins (Figure (Figure7,7, A and B). It is likely, therefore, that differences in the abilities of different anchored catenins to interact with cadherins may underlie the observed differences in their ability to activate gene expression in different systems.
It is already clear that different TCF-regulated promoters differ in their requirements for catenin cofactors. For example, the T-cell receptor α-enhancer is regulated by LEF-1 in a β-catenin–independent, ALY-dependent manner (Hsu et al., 1998 ), whereas other TCF-regulated promoters, such as that in the cyclin D1 gene, appear to require β-catenin as a coactivator (Tetsu and McCormick, 1999 ) and may respond to cnxPg differently than does the OT promoter.
Although cnxPgs are artificial proteins expressed from exogenous DNAs, it is known that endogenous β-catenin and plakoglobin can form complexes with several cytoplasmic proteins. Indeed, interactions of β-catenin and plakoglobin with APC, Axin, Conductin/Axil, Presenilin, cadherins, EGFR, fascin, pontin-52, and phosphatases have all been described (see above). Binding to cadherins clearly blocks the signaling activity of plakoglobin and β-catenin (see above). It is not known, however, whether interactions between β-catenin (or plakoglobin) and other proteins inhibit the ability of the complex to bind to TCF proteins. If such interference does not occur, cytoplasmic sequestration of TCFs could play a physiological role in the regulation of Wnt signaling. In fact, studies of endoderm formation in Caenorhabditis elegans indicate that nuclear levels of the TCF-like transcription factor pop-1 are reduced in response to Wnt signaling (Rocheleau et al., 1997 ; Thorpe et al., 1997 ) (Figure (Figure9C).9C). This result supports our premise that regulation of the intracellular distribution of TCFs may be involved in vertebrate Wnt signaling as well.
We thank Amy Hopkins for technical assistance with cell culture and plasmid growth, Aaron Zorn for stimulating discussions of Wnt signaling, and Rudolf Grosschedl, Pierre McCrea, Kathy Jones, Hans Clevers, Miranda Molenaar, Barry Gumbiner, Sergie Sokol, Michael Sargent, Thomas Kurth, Peter Hausen, Paul Robbins, Werner Franke, Jacqueline Lee, and Randy Moon for supplying cDNAs and antibodies. In particular, we thank Richard Nelson and Barry Gumbiner for examining the specificity of the anti-APC antibodies used in this study and Mark Peifer for discussion of work before publication. This work was supported by a grant from the National Institutes of Health (GM54001) to M.W.K. B.O.W. is a Fellow of the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation. G.D.B. is a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.